IDEXX Laboratories, Inc. (IDXX) Earning

NASDAQ Currency in USD Disclaimer

$413.62

north_east $0.46 (0.11%)
Day's range
$409.84
Day's range
$414.25

IDEXX Laboratories, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 2 $2.71 $2.72 $2.71
Q2 2024 2 $2.88 $2.88 $2.88
Q3 2024 2 $2.67 $2.69 $2.68
Q4 2024 7 $2.34 $2.47 $2.40
Q1 2025 6 $2.94 $3.07 $3.00
Q2 2025 5 $3.16 $3.25 $3.20
Q3 2025 5 $3.05 $3.13 $3.08
Q4 2025 5 $2.69 $2.76 $2.72
Q1 2026 2 $3.29 $3.38 $3.32
Q2 2026 2 $3.48 $3.58 $3.52
Q3 2026 2 $3.42 $3.51 $3.46
Q4 2026 2 $3.11 $3.19 $3.14

IDEXX Laboratories, Inc. Earnings Date And Information

IDEXX Laboratories, Inc. last posted its earnings results on Thursday, October 31st, 2024. The company reported $2.8 earnings per share for the quarter, topping analysts' consensus estimates of $2.68 by $0.12. The company had revenue of 975.54 M for the quarter and had revenue of 3.66 B for the year. IDEXX Laboratories, Inc. has generated $10 earnings per share over the last year ($10.06 diluted earnings per share) and currently has a price-to-earnings ratio of 39.3. IDEXX Laboratories, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 3rd, 2025 based on prior year's report dates.

IDEXX Laboratories, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
10/31/2024 Q3 2024 $2.68 $2.83 0.15 $980.32 M $975.54 M
08/06/2024 Q2 2024 $2.88 $2.46 -0.42 $1.01 B $1.00 B
05/01/2024 Q1 2024 $2.67 $2.84 0.17 $964.10 M
02/22/2024 Q4 2023 $2.34 $901.60 M
11/01/2023 Q3 2023 $2.37 $2.55 0.18 $926.88 M $915.53 M
08/01/2023 Q2 2023 $2.47 $2.70 0.23 $934.59 M $943.63 M
05/02/2023 Q1 2023 $2.42 $2.58 0.16 $900.20 M
02/16/2023 Q4 2022 $2.08 $828.57 M
11/01/2022 Q3 2022 $2.04 $2.17 0.13 $830.00 M $841.66 M
08/02/2022 Q2 2022 $1.56 $1.57 0.01 $863.14 M $860.55 M
05/04/2022 Q1 2022 $2.26 $2.30 0.04 $836.55 M
02/16/2022 Q4 2021 $1.92 $801.09 M
11/02/2021 Q3 2021 $1.91 $2.06 0.15 $797.61 M $810.42 M
07/30/2021 Q2 2021 $2.02 $2.37 0.35 $788.86 M $826.14 M
05/04/2021 Q1 2021 $1.72 $2.39 0.67 $777.71 M
02/12/2021 Q4 2020 $2.04 $720.94 M
10/29/2020 Q3 2020 $1.43 $1.71 0.28 $672.48 M $721.79 M
07/31/2020 Q2 2020 $1.17 $1.75 0.58 $593.05 M $637.59 M
04/30/2020 Q1 2020 $1.20 $1.31 0.11 $626.34 M
02/14/2020 Q4 2019 $1.05 $605.45 M
 

IDEXX Laboratories, Inc. Earnings: FAQ's

When is IDEXX Laboratories, Inc.'s earnings date?

IDEXX Laboratories, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 3rd, 2025 based off last year's report dates.

Did IDEXX Laboratories, Inc. beat their earnings estimates last quarter?

In the previous quarter, IDEXX Laboratories, Inc. (:IDXX) reported $2.8 earnings per share (EPS) to beat the analysts' consensus estimate of $2.68 by $0.12.

How can I listen to IDEXX Laboratories, Inc.'s earnings conference call?

The conference call for IDEXX Laboratories, Inc.'s latest earnings report can be listened to online.

How can I read IDEXX Laboratories, Inc.'s conference call transcript?

The conference call transcript for IDEXX Laboratories, Inc.'s latest earnings report can be read online.

How much revenue does IDEXX Laboratories, Inc. generate each year?

IDEXX Laboratories, Inc. (:IDXX) has a recorded annual revenue of $3.66 B.

How much profit does IDEXX Laboratories, Inc. generate each year?

IDEXX Laboratories, Inc. (:IDXX) has a recorded net income of $3.66 B. IDEXX Laboratories, Inc. has generated $10.17 earnings per share over the last four quarters.

What is IDEXX Laboratories, Inc.'s price-to-earnings ratio?

IDEXX Laboratories, Inc. (:IDXX) has a price-to-earnings ratio of 39.3 and price/earnings-to-growth ratio is 14.3.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED